Clinical trial
Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin…
NCT00173862 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00173862 |
|---|---|
| Title | Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC |
| Official title | A Phase II Study of Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced Transitional Cell Carcinoma |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Transitional Cell Carcinoma |
| Intervention type | Drug |
| Interventions | Gemcitabine, Ifosfamide |
| Enrollment | 18 |
| Start date | May 1, 2000 |
| Completion | Jun 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 25, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: